SCA
CL icon

Sippican Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Sippican Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$571K Sell
6,697
-300
-4% -$26.7K 0.39% 74
2025
Q4 		$553K Sell
6,997
-133
-2% -$10.4K 0.36% 79
2025
Q3 		$570K Hold
7,130
– – 0.38% 78
2025
Q2 		$648K Hold
7,130
– – 0.47% 69
2025
Q1 		$668K Sell
7,130
-70
-1% -$6.27K 0.5% 66
2024
Q4 		$655K Buy
7,200
+65
+0.9% +$6.2K 0.48% 68
2024
Q3 		$741K Sell
7,135
-100
-1% -$10.2K 0.52% 61
2024
Q2 		$702K Sell
7,235
-76
-1% -$7.01K 0.56% 62
2024
Q1 		$658K Sell
7,311
-2,460
-25% -$208K 0.51% 69
2023
Q4 		$779K Buy
9,771
+2,450
+33% +$184K 0.61% 64
2023
Q3 		$521K Buy
7,321
+36
+0.5% +$2.69K 0.47% 68
2023
Q2 		$561K Sell
7,285
-115
-2% -$8.9K 0.52% 66
2023
Q1 		$556K Sell
7,400
-50
-0.7% -$3.72K 0.53% 70
2022
Q4 		$587K Sell
7,450
-162
-2% -$12.1K 0.56% 65
2022
Q3 		$535K Hold
7,612
– – 0.56% 68
2022
Q2 		$610K Sell
7,612
-72
-0.9% -$5.63K 0.61% 68
2022
Q1 		$583K Sell
7,684
-25
-0.3% -$1.98K 0.48% 70
2021
Q4 		$658K Sell
7,709
-391
-5% -$30.5K 0.56% 66
2021
Q3 		$612K Sell
8,100
-5
-0.1% -$397 0.53% 69
2021
Q2 		$659K Hold
8,105
– – 0.57% 64
2021
Q1 		$639K Hold
8,105
– – 0.59% 61
2020
Q4 		$693K Sell
8,105
-2,585
-24% -$214K 0.75% 54
2020
Q3 		$825K Buy
10,690
+1,435
+16% +$109K 1.03% 40
2020
Q2 		$678K Sell
9,255
-1,145
-11% -$81.3K 0.91% 46
2020
Q1 		$690K Sell
10,400
-610
-6% -$43K 1.12% 37
2019
Q4 		$758K Buy
11,010
+655
+6% +$44.7K 0.84% 49
2019
Q3 		$761K Sell
10,355
-100
-1% -$7.25K 0.92% 45
2019
Q2 		$749K Sell
10,455
-70
-0.7% -$4.97K 0.88% 44
2019
Q1 		$721K Buy
10,525
+1,100
+12% +$71.1K 0.86% 45
2018
Q4 		$561K Buy
9,425
+600
+7% +$37.5K 0.76% 52
2018
Q3 		$537K Sell
8,825
-2,475
-22% -$165K 0.62% 58
2018
Q2 		$732K Sell
11,300
-75
-0.7% -$4.91K 0.73% 51
2018
Q1 		$815K Hold
11,375
– – 0.85% 45
2017
Q4 		$858K Sell
11,375
-150
-1% -$11K 0.84% 50
2017
Q3 		$840K Hold
11,525
– – 0.86% 47
2017
Q2 		$854K Hold
11,525
– – 0.93% 44
2017
Q1 		$844K Buy
11,525
+200
+2% +$14K 0.9% 43
2016
Q4 		$741K Hold
11,325
– – 0.78% 47
2016
Q3 		$840K Hold
11,325
– – 0.96% 37
2016
Q2 		$829K Hold
11,325
– – 0.99% 40
2016
Q1 		$800K Buy
11,325
+49
+0.4% +$3.26K 1.02% 40
2015
Q4 		$751K Hold
11,276
– – 0.95% 39
2015
Q3 		$716K Sell
11,276
-350
-3% -$22.9K 0.91% 41
2015
Q2 		$760K Sell
11,626
-99
-0.8% -$6.72K 0.77% 53
2015
Q1 		$813K Hold
11,725
– – 0.83% 43
2014
Q4 		$811K Sell
11,725
-250
-2% -$16.9K 0.81% 44
2014
Q3 		$781K Buy
+11,975
New +$790K 0.79% 49

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sippican Capital Advisors's CL Position: Q1 2026 in Review

Sippican Capital Advisors reduced its Colgate-Palmolive (CL) stake by 4.3% in Q1 2026, selling an estimated $26.7K and leaving 6,697 shares worth $571K. The position accounts for 0.39% of the portfolio, ranked #74.

Sippican Capital Advisors first reported a position in CL in Q3 2014 and has held it in 47 quarters since. The position peaked at $858K in Q4 2017. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Sippican Capital Advisors held 6,697 shares of Colgate-Palmolive worth $571K as of Q1 2026.
  • Sippican Capital Advisors sold 300 Colgate-Palmolive shares in Q1 2026, an estimated $26.7K.
  • Colgate-Palmolive made up 0.39% of Sippican Capital Advisors's portfolio in Q1 2026, its #74 holding.
  • Sippican Capital Advisors first reported a position in Colgate-Palmolive in Q3 2014 and has held it in 47 quarters since.
  • Sippican Capital Advisors's Colgate-Palmolive position peaked at $858K in Q4 2017.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Sippican Capital Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.